Get the up-to-date 2004 xeloda action plan-2024 now

Get Form
capecitabine dose calculator Preview on Page 1

Here's how it works

01. Edit your form online
01. Edit your form online
Type text, add images, blackout confidential details, add comments, highlights and more.
02. Sign it in a few clicks
02. Sign it in a few clicks
Draw your signature, type it, upload its image, or use your mobile device as a signature pad.
03. Share your form with others
03. Share your form with others
Send it via email, link, or fax. You can also download it, export it or print it out.

How to edit 2004 xeloda action plan online

Form edit decoration
9.5
Ease of Setup
DocHub User Ratings on G2
9.0
Ease of Use
DocHub User Ratings on G2

With DocHub, making adjustments to your paperwork takes only some simple clicks. Follow these quick steps to edit the PDF 2004 xeloda action plan online for free:

  1. Register and log in to your account. Log in to the editor with your credentials or click Create free account to examine the tool’s functionality.
  2. Add the 2004 xeloda action plan for editing. Click the New Document button above, then drag and drop the file to the upload area, import it from the cloud, or using a link.
  3. Change your document. Make any adjustments required: insert text and pictures to your 2004 xeloda action plan, underline important details, erase parts of content and substitute them with new ones, and add symbols, checkmarks, and areas for filling out.
  4. Complete redacting the template. Save the updated document on your device, export it to the cloud, print it right from the editor, or share it with all the people involved.

Our editor is very user-friendly and effective. Try it out now!

See more 2004 xeloda action plan versions

We've got more versions of the 2004 xeloda action plan form. Select the right 2004 xeloda action plan version from the list and start editing it straight away!
Versions Form popularity Fillable & printable
2004 4.8 Satisfied (105 Votes)
be ready to get more

Complete this form in 5 minutes or less

Get form

Got questions?

We have answers to the most popular questions from our customers. If you can't find an answer to your question, please contact us.
Contact us
88.9% of the patients were alive at 3 years, and 89.2% vs. 83.6% were alive at 5 years), and survival was longer in the group than in the control group (hazard ratio for death, 0.59; 95% CI, 0.39 to 0.90; P=0.01).
Xeloda () - 3 Indications for the treatment of breast cancer; approved April 1998.
Uses: Xeloda often is used in combination with other anticancer medicines. Typically it's used to treat metastatic breast cancer that has stopped responding to Taxol, Taxotere, and Adriamycin.
can reduce the production of white blood cells by the bone marrow, making you more prone to infection. This effect can begin seven days after treatment has been given, and your resistance to infection usually docHubes its lowest point 1014 days after chemotherapy.
In a phase II trial of 163 paclitaxel-refractory patients with metastatic breast cancer, the overall response rate with Xeloda was 20%, with three complete responses, and the median survival was 12.8 months. A total of 20% of patients experienced a Clinical Benefit Response (a composite assessment of clinical benefit).
be ready to get more

Complete this form in 5 minutes or less

Get form

People also ask

Radiation therapy uses high energy beams to kill tumor cells and shrink tumors. Chemotherapy drugs, such as oxaliplatin, leucovorin, , and work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.
Among those women, 79 percent of Xeloda patients were alive after five years, compared with 70 percent of placebo patients. The main side effect -- affecting almost three-quarters of patients -- was hand-foot syndrome. That's a reddening and swelling of the palms and soles of the feet.
is used to treat breast, colon, or rectal cancer. It works by slowing or stopping the growth of cancer cells.
Xeloda (chemical name: ) is a chemotherapy medicine often used in combination with other anticancer medicines. Typically, its used to treat advanced-stage breast cancer that has stopped responding to certain other chemotherapy medicines.
Xeloda is available in 500mg tablets. Xeloda is an approved oral drug developed by F. Hoffmann-La Roche (Roche) for treating metastatic colorectal cancer and breast cancer. The drug was first approved in the US and EU in 2001 as monotherapy for treating colorectal cancer.

Related links